Does Insurance Cover Wegovy's High Cost?
Wegovy (semaglutide) costs about $1,350 per month without insurance, making coverage a key factor for affordability.[1] Most major insurers, including Medicare Part D, commercial plans like those from UnitedHealthcare and Blue Cross Blue Shield, and Medicaid in many states, cover Wegovy when prescribed for FDA-approved chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with related conditions like hypertension or type 2 diabetes.[2][3] Prior authorization is standard, requiring proof of medical necessity, failed prior weight loss attempts, and ongoing monitoring.[4]
What If It's Prescribed for Weight Loss Off-Label?
Coverage drops sharply for off-label use, such as general weight loss without qualifying conditions. Medicare explicitly excludes weight loss drugs under Part D, though some Medicare Advantage plans add coverage.[5] Many commercial insurers deny claims here, treating it as cosmetic rather than medically necessary.[6] Patients often pay full out-of-pocket or turn to manufacturer savings cards.
How Much Will I Pay With Coverage?
Even with approval, copays range from $25–$100 monthly after deductibles, depending on plan tier (often Tier 3 or 4).[7] High-deductible plans can mean $2,000+ upfront. Novo Nordisk's Wegovy Savings Card caps costs at $25/month for eligible commercially insured patients (income limits apply; not for government insurance).[8] Uninsured patients qualify for similar discounts down to $199/month via NovoCare.[1]
Why Do Insurers Often Deny Coverage?
Denials stem from high demand straining formularies, step therapy requirements (e.g., try cheaper options like phentermine first), and debates over long-term cost-effectiveness.[9] Obesity's classification as a chronic disease since 2013 has improved access, but 40–50% of prior authorizations get rejected initially, with appeals succeeding in about 60% of cases.[10]
Medicare and Government Coverage Specifics
Original Medicare Part D covers Wegovy for weight management with prior authorization since 2024 updates, reversing prior exclusions.[11] Medicare Advantage plans vary widely—check via Medicare's plan finder. Medicaid covers it in 40+ states for eligible patients, often with BMI and comorbidity rules.[12] TRICARE and VA provide coverage for qualifying veterans.
Alternatives if Insurance Says No
Switch to Ozempic (same drug, lower-dose for diabetes), which has broader coverage since it's not weight-loss branded—copays often under $50.[13] Compounded semaglutide from pharmacies costs $200–$500/month but lacks FDA approval and faces shortages/regulation risks.[14] Other GLP-1 drugs like Zepbound (tirzepatide) compete with similar coverage hurdles but potentially lower list prices (~$1,100/month).[15]
How to Get Coverage Approved Faster
Submit BMI documentation, physician notes on comorbidities, and lab results with prior auth requests. Use tools like GoodRx for price comparisons or Novo Nordisk's pharmacy locator for covered sites.[16] Appeal denials with clinical data showing 15–20% average weight loss from trials.17
[1]: NovoCare.com
[2]: FDA.gov
[3]: UnitedHealthcare
[4]: CMS.gov
[5]: KFF.org
[6]: IQVIA Institute
[7]: GoodRx.com
[8]: Wegovy.com
[9]: Health Affairs
[10]: CoverMyMeds
[11]: CMS.gov
[12]: Medicaid.gov
[13]: Ozempic.com
[14]: FDA.gov
[15]: Zepbound.com
[16]: NovoCare.com